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Summary
This is a critical review of the medical, ethical, judicial
and financial aspects of the so called “social freezing”,
the cryopreservation of a woman’s oocytes for non-medical
purposes. The possibility of storing the eggs of fertile wo-
men in order to prevent age-related fertility decline is being
widely promoted by fertility centres and the lay press
throughout the world.
Research data has shown that social freezing should ideally
be performed on women around 25 years of age in order to
increase their chances of a future pregnancy. In reality, it is
mostly performed after the age of 35.
Unfortunately, social freezing is in general not a solution
for the underlying societal problems to fit in with profes-
sionally active women and having children. It only delays
the existing problems. Furthermore, it creates a lot of po-
tential new problems. A great deal more should be under-
taken to offer real solutions to the underlying societal prob-
lems which are in part: pre-school education, care in the
event of childhood illness, and the many weeks of school
holidays, acceptance of professionally active women hav-
ing children, and more job offers with a workload <100%.).
Furthermore, society should be informed about the decreas-
ing chances of pregnancy with increasing maternal (and pa-
ternal) age as well as the increasing risks of miscarriage
and obstetric/neonatal complications.
Detailed information for woman considering social freez-
ing is crucial. Every doctor, proposing social freezing to his
patients, should be up to date with all these details. Follow-
up studies on the outcome of these children are needed.
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Introduction
Egg freezing for social reasons means the cryopreservation
of a woman’s oocytes for non-medical purposes, i.e. as pre-
vention for age-related fertility decline. To be more pre-
cise, social freezing means egg storing of a healthy, fertile
woman (one or more in-vitro fertilisation (IVF)-stimulation
cycles), in order to have a pregnancy after her career, i.e. at
the age of 45 to 50.
For about 10 years, in parallel with the technical improve-
ment of oocyte freezing, the possibility of egg storing for
non-medical purposes is more extensively discussed and
more commonly accepted by the general population and
expert committees; not only in the United States, but also
in Europe. Likewise, in Switzerland, more emphasis is fo-
cussed on the promotion of social freezing. Articles in the
lay press are publicising the theme and lectures are regu-
larly organised for lay people, by centres which offer this
practice. In addition, beautiful advertising brochures are
sent to gynaecologists in order to promote social freezing
to their patients. Information is widespread on the internet.
Here are examples of messages conveyed from the differ-
ent brochures: “I choose the right moment”; “You choose
your personal best”; “Art, literature, fashion, children – too
much at once? You’d like to enjoy every day of your life
and spend your life in your own way. Take advantage of
your new freedom to act!”; “Develop your business plan!
You’ve got innovative ideas and want to realise your full
potential. Besides, you want to have children – some day.
Oocyte preservation offers you fertility freedom!” By the
same token, it is proposed to audiences at Swiss congress
lectures, to offer her one or more cycles of “Social Freez-
ing” as a birthday present to, for example, a daughter study-
ing medicine.
It is a fact that the peak of reproductive performance for
women is 25 years. After that reproductive aging begins
and pregnancy rates decline relatively fast from 35 years.
Conversely miscarriage rates rise exponentially. After the
age of 43 years, chances of becoming pregnant are ex-
tremely low. It is also a fact that combining career and
motherhood, at the same time, is a very difficult challenge
for women. Social freezing is advertised to harmonise these
incompatibilities. But is it really the solution to the prob-
lem? Or could it also create other problems?
Neonatal and maternal risks ofprimiparity at an advanced maternalage (≥40 years)
Maternal risks
With increasing age, pre-pregnancy chronic medical condi-
tions and with that obstetrical risks and adverse birth out-
comes rise [1–4]. Consequently, pregnancy complications
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are very elevated (84.7%) compared to younger women,
i.e. gestational hypertension (45% vs 6.4%), pre-eclampsia
(18.3% vs 3%‒4%), gestational diabetes (42.7% vs 6.1%),
cerclage (9.2%), preterm delivery (33.8%), hospitalisation
during pregnancy (48.1%), caesarean sections (93.9% vs
25%) [5]. Age is also an independent risk factor for pla-
centa praevia, placental abruption, perinatal mortality and
especially foetal death [6]. Primiparity may be a specific
risk factor [7], as preeclampsia is regarded as a disease of
nulliparous women [8, 9]. Even though maternal mortality
rates are very low in Europe, they are increasing with in-
creasing age [10].
Moreover, postnatal depression is significantly elevated
with increasing maternal age, (OR = 0.96, p-value = 0.019),
and this, independent of socioeconomic and reproductive
characteristics, conjugal status or substance consumption
[11].
Neonatal risks
Due to advanced maternal age and pregnancy complica-
tions, neonatal complications are also increased, compris-
ing prematurity (33.8% vs 7% in younger women) and
lower mean birth weights among infants of women ≥50
years old (p = 0.0003; p = 0.01 for singletons and p = 0.04
for multiples) compared with younger women [5]. The in-
cidence of low birth weight (LBW) also rises with increas-
ing maternal age. Among women aged 50–65 years, 68.5%
of the infants have a LBW [5]. LBW and its resulting con-
sequences are one of the main causes for perinatal morbid-
ity and mortality. It has to be mentioned that intrauterine
growth restriction, which is correlated with increasing ma-
ternal age, was found to alter foetal programming and can
lead to lifelong health implications, i.e. cardiovascular dis-
ease, type 2 diabetes mellitus and obesity [12].
Conversely, it seems that children of 40 year old mothers
have fewer hospital admissions and unintentional injuries,
better language development and fewer social and emo-
tional difficulties [13]. In addition, other data show that
older parents can provide advantages, such as: relational
stability, parent-child interactions and financial situation
compared to younger parents [14].
Risks and adverse effects of IVF-intracytoplasmatic sperm injection(ICSI) treatments
Perinatal outcome after ART
The main risk of IVF-ICSI is multiple pregnancies (essen-
tially twins, but also triplets). It is very well known and
does not require explanation that risks of perinatal morbid-
ity and mortality are extremely increased in multiples com-
pared to singletons.
However, after ART, even among singletons a heightened
risk of adverse perinatal outcomes has been observed as
compared to spontaneous conception, including low and
very low birth weight [15–19]. Three meta-analyses
[20–22] have supported these data and a consensus state-
ment of the National Institute of Health suggests informing
and warning patients concerning these risks [23]. A recent
meta-analysis has shown an elevated risk for preterm birth
even in singletons after elective single embryo transfer,
compared to spontaneously conceived singletons [24]. The
reasons for these adverse perinatal outcomes are not yet
elucidated; infertility itself, ovarian stimulation and in-
vitro manipulations are taken into consideration.
And yet another unresolved concern is the potential risk
of epigenetic changes and imprinting defects after in-vitro
cultures, especially after extended culture of embryos
(blastocyst stage) [25].
Malformation rate in children conceived after IVF-
ICSI
Since the delivery of the first IVF baby, Louise Brown in
1978, a vast number of follow-up studies have been un-
dertaken. While initially no differences between malforma-
tion rates after spontaneous conception and IVF-ICSI were
found [26, 27], subsequently data showed significant elev-
ated malformation rates in children conceived after IVF-
ICSI [28–31].
The reasons for this are not clear today; paternal and mater-
nal socio-demographic and anamnestic risk factors as well
as infertility, ovarian stimulation and in-vitro manipula-
tions are under discussion. Accordingly, it is unclear today
if IVF in patients without infertility would lead to the same
elevated malformation rate in children or if it would be dif-
ferent because there is no inherent infertility factor.
Malformation rate in children conceived after freezing-
thawing of unfertilised oocytes and consecutive ICSI
Research data available in the literature is minimal. A re-
view on 58 articles (23 case reports and 35 case series), in-
cluding 308 children after slow freezing and 289 after vitri-
fication, showed no elevation of malformation rate (1.3%)
[32]. Further outcome studies are essential in order to have
conclusive data.
Outcome of children after vitrification
Because of the formation of ice crystals in the oocyte
(which can destroy the skeleton of the cell), cryoprotectants
are added. However, fertilisation and pregnancy rates with
the conventional slow freezing method of oocytes are lim-
ited.
Vitrification is a newer technique with an ultra rapid cool-
ing of the oocytes in order to avoid ice crystals. The first
baby after vitrification was born in 1999, a healthy girl.
The only existing follow-up study, including 200 children,
is reassuring [33]. However, meaningful data are lacking.
Besides, there is no data available on the long-term follow-
up of these children.
Long term health effects in children conceived after
IVF-ICSI
The risk of long term health effects in children conceived
after IVF-ICSI cannot be specified yet. Study results have
shown an increased cardiovascular and cardio metabolic
risk in healthy children after IVF-ICSI [34–36]. However,
the clinical impact of these findings and the clinical long
term consequences are not yet clear. The oldest IVF chil-
dren are in their thirties and the oldest ICSI children are just
around twenty years of age. There is a need to investigate
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the long term health of IVF-ICSI-children and their risk of
diseases later in life in epidemiologic follow-up studies.
Risks of failure (respectively chances of success)
In Switzerland, mean pregnancy rates per transfer (of 2 em-
bryos) are 19.5% after freezing and thawing of the (pre-)
embryos [37].
These numbers cannot be adopted for women who perform
social freezing because this comprises freezing and thaw-
ing of already fertilised oocytes (pre-embryos) which are
known to have a better implantation potential after thawing
compared to non-fertilised frozen oocytes, even though
cryopreservation techniques (i.e. vitrification) nowadays
have made substantial progress.
Recent data show that survival and fertilisation rates of un-
fertilised oocytes after vitrification are significantly higher
compared to those after slow freezing (78.9% vs 57.9% and
72.8% vs 64.6%) [38].
According to the results of a meta-analysis, the implant-
ation potential of one metaphase-II oocyte that has sur-
vived the freezing-thawing process is estimated to be 7%
(95%CI: 4.3–11.2) after slow-freezing and 7.7% (95%CI:
5.3–11) after vitrification [39]. Other data show that the im-
plantation rate per thawed oocyte after vitrification can be
as high as per fresh oocyte (around 12.9%) [40]. At the
same time, slow freezing protocols are much more effic-
acious nowadays and can reach 11.8% per thawed oocyte
in some centres, according to some authors [41]. (Implant-
ation rate is defined as the probability of a single embryo
to implant after transfer and it is calculated as the number
of gestational sacs per 100 transferred embryos. It has to
be stressed that the implantation potential of an embryo is,
among other factors, dependent on maternal age.)
However, there are no concrete data in literature concern-
ing the “baby take home rate” per thawed unfertilised oo-
cyte.
The chances of becoming pregnant after preservation of
oocytes depend on the one hand, on the number of the cryo-
preserved oocytes, but on the other hand, on the biological
age with its impact on spindle configuration and chromo-
somal arrangement. Both decrease dramatically with age.
Women, considering social freezing, are unfortunately very
often around 38 years of age, which leads to a very low
cost-efficiency.
Risks of ovarian hyperstimulation syndrome
According to the literature, the risk of women having ovari-
an hyperstimulation syndrome lies between 1% and 10%.
In this special collective, the risk of relevant hyperstimu-
lation syndrome is estimated to be lower (around 1%), be-
cause no transfer is performed in these women and special
prevention measures (i.e. antagonist protocols with ovula-
tion induction by agonists) can be applied.
Risks of oocyte pick-up
The risk of women incurring complications due to the oo-
cyte pick-up (bleeding, infection, injury to other organs or
complications due to anaesthesia) is very low (1/1000).
Legal issues of fertility preservation inSwitzerland
The Swiss law of assisted reproductive technologies came
into effect 01 January 2001 [42]. Different aspects of IVF-
ICSI are regulated, namely what is allowed to be cryopre-
served and how long: oocytes/ovarian tissue, sperm/testic-
ular tissue and pre-embryos can be frozen for up to 5 years
(article 15). In the case of medical treatment of an illness,
such as cancer which could cause infertility, gametes can
be cryopreserved longer (article 15). It is forbidden by law
to freeze embryos (article 17.3).
In the context of the Swiss law, social freezing in Switzer-
land makes no sense. Ideally, the woman should be around
25 years to do a social freezing. But the “Career problem”
is generally not solved within 5 years, and rarely nowadays
by the age of 30. On the other hand, a cryopreservation at
the age of 35 in order to plan a pregnancy at the age of 40
is too late because of the biological aging of the oocytes.
Nonetheless, social freezing is proposed and performed in
Swiss fertility centres. Patients still have the possibility to
transfer their oocytes in fertility centres abroad, where oth-
er legal regulations exist.
Another unsolved juridical issue of the Swiss law is that
IVF-treatments are only allowed in the case of infertility,
which is not at all the case of young career women who
are drawn to social freezing. But as always in legal issues,
there exist different judicial interpretations. According to
those, stimulation and freezing of oocytes have to be com-
pletely separated from the process of IVF-ICSI-fertilisa-
tion. As fertilisation would only be undertaken when the
woman has become infertile due to age, social freezing
would be legal in Switzerland according to this interpreta-
tion of the law.
Ethical issues
Reproductive autonomy versus well-being of the child
An ethical principle is the respect for the autonomy of
people. People can decide whether to have children, with
whom, how many etc. Advocates of social freezing extra-
polate that persons should also have the right to decide the
moment to reproduce, according to their priorities (child-
bearing in relation to other life plans).
At the opposite end of the spectrum is the well-being of
the child. According to Swiss law, the well-being of the fu-
ture child is the first and supreme principle. In keeping with
this, elevated risk of potential medical complications for
the future child should be avoided. Besides that, it is prim-
ordial for the child’s well-being to have young and vigor-
ous (or healthy) parents. Consequently, situations such as,
65–70 years and older mothers/parents with fully pubes-
cent children should be averted.
Another ethical issue is that social freezing is the embodi-
ment of the trend in society to accept less and less the fi-
niteness and unavailability of the human life.
Other concerns are the possibility to create high (and po-
tentially false) hopes and introducing medical processes to
primary fertile women.
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Financial issues
Social freezing is a very expensive procedure and the cost
is entirely assumed by the woman/couple in Switzerland.
Cost of only one cycle of IVF-stimulation (with oocyte
pick-up and -freezing) can vary between CHF 3,000 and
CHF 5,300. Several IVF-stimulation cycles are promoted
in order to increase the chances of a pregnancy.
Additionally, annually storage costs have to be added
(between CHF 200 and CHF 300 per year).
And last but not least, costs for one thawing cycle (includ-
ing fertilisation with the partner’s sperm) are in addition
(between CHF 2,500 and CHF 3,500). In general, several
thawing cycles are necessary to get an ongoing pregnancy.
A cost-based decision analysis on the cost efficiency of fer-
tility preservation for social indications has come to the
conclusion that neither oocyte cryopreservation nor ovari-
an tissue cryopreservations are cost-effective for otherwise
healthy women planning delayed childbearing [43].
Arguments for social freezing
Arguments for social freezing are that the ethically delicate
oocyte donation as well as the burden of ineffective fertility
treatments and chromosomal abnormalities, at an older age,
could be avoided. Social freezing “promises” women to
practice their reproductive autonomy and simultaneously to
increase their chances of genetic motherhood.
Social freezing can give some hope to women who have
not had the chance to meet a partner. To the present-day,
unfortunately, many intelligent and well educated women
are confronted with the phenomenon of staying single.
Advocates of social freezing consider age related fertility
decline to be a medical problem which should be prevented
by this relatively new technology. In Israel for example,
women between 30 to 41 years of age are allowed to under-
go four retrieval cycles or the retrieval of 20 oocytes if they
fear a decline of fertility; thawed fertilised eggs can be im-
planted until the age of 54 [44]. Costs are generally taken
over by various Israeli health funds.
Arguments against social freezing
Every medical intervention has its inherent risks. As men-
tioned above, even today, there exists for the future child
(and also for the mother) many health risks due to the IVF-
ICSI treatment, especially in woman over 45 years of age.
Beyond that, there are many unresolved questions concern-
ing the health and the outcome/follow-up of IVF-ICSI chil-
dren. In general, these risks are considered to be relatively
low and IVF-ICSI treatment in the case of infertility is re-
garded as acceptable. But, it is open to question whether to
expose healthy women without inherent infertility factors
and their future children, unnecessarily, to adverse physic-
al outcomes (not to mention the psychological problems of
the children whose mothers could be taken for their grand-
mothers and all the other ethical issues).
In addition, it has to be considered that pregnancy, delivery
and raising children does not ever really fit into a woman’s
career plan, independently of age. There is no “ideal time”
and it is always complicated to organise child care
whatever the age of the mother, e.g. before and after school,
in the case of childhood illness, during the weeks and
months of school holidays and so on. Energy and force of
human beings decrease slowly but surely with age. A wo-
man of around 35 years can cope with concomitant short
nights and the stress of performing during the day, whereas
for women of 45–50 this is generally a much more difficult
task.
It has also to be considered that grand-parents, who
nowadays help a lot in looking after their grandchildren
during the school holidays or in the case of illness, would
be in the case of delayed motherhood (after social freezing)
either in a state of health incompatible compared to the en-
ergy of the children, or deceased. It has also to be men-
tioned that later on, these old parents will for the same reas-
ons not be able to look after their grandchildren. And it has
also not to be forgotten that the resulting children could
be very ashamed to have parents who could be perceived
as their grand-parents, possibly leading to psychological
problems.
Social freezing does not solve one problem; it only delays
the time of the multiple problems to be confronted, espe-
cially in Switzerland with its rigid structures and the pater-
nalistic view of the role of the woman in society.
Finally, even with 20 stored oocytes, there is no a guarantee
of getting pregnant after social freezing. Moreover, the risk
of reaching 45 or 50 years of age without becoming preg-
nant, despite of a lot of physical and psychological stress
(not to mention the financial issues) is not negligible.
Future strategies
Unfortunately, reports in the lay press on more or less fam-
ous women giving birth to a child at around the age of 50
are presenting a distorted picture of reality. Studies around
the world have shown that young people are not aware
of the natural limits of human fertility [45, 46]. Conse-
quently, school-children should be informed of the decreas-
ing chances of pregnancy with increasing maternal age as
well as the increasing risks of miscarriage and obstetrical/
neonatal complications.
Moreover, substantial changes in social structures, i.e.
crèches, day nurseries, day schools, child care during the
long holiday periods and care of ill children are needed.
Additionally, major rethinking of the perception of ideals
and traditional gender roles is urgently required, especially
in the quite paternally orientated country of Switzerland.
Currently, women who have children are often not con-
sidered suitable for leadership, fearing that their perform-
ance could be diminished. This thinking is probably even
more pronounced in the German speaking part of Switzer-
land compared to the Romandie.
Significant efforts have to be made in order to counteract
these problems. Politicians of different parties, supported
by medical societies, e.g., for example, the Swiss Society
of Gynaecology and Obstetrics, should urgently work hand
in hand in order to solve the aforementioned problematic
issues.
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Conclusion
Social freezing should be performed around the age of 25
years in order to improve chances of becoming pregnant. It
could give some hope for women who unfortunately do not
find a partner in their thirties.
Social freezing is regrettably not a realistic solution for wo-
men seeking compatibility with their professional and fam-
ily life. On the contrary, it creates a lot of potentially new
problems.
A lot of efforts should be made to solve the underlying so-
cietal problems (preschool, child care in case of illness and
during the months of school holidays, acceptance of pro-
fessionally active women having children, job offers with a
workload <100%, job sharing possibilities etc.).
Furthermore, society should be informed about the decreas-
ing chances of pregnancy with increasing maternal (and pa-
ternal) age as well as the increased risks of miscarriage and
obstetric/neonatal complications.
Although social freezing is not a solution for the underlying
problems, nonetheless it can be beneficial in specific situ-
ations. Detailed information on the (limited) possibility of
health risks for the future child (especially in the case of
delayed motherhood), the yet unsolved questions about the
outcome of IVF-ICSI children and of the relatively new
technique of vitrification, information on the risk of failure,
the judicial, ethical and psychological issues and last but
not least on the high costs is crucial. Every doctor, propos-
ing social freezing to his patients, should be familiar with
up to date and all the above mentioned data.
Follow-up studies on the outcome of the children after vit-
rification and particularly after social freezing are urgently
needed.
Acknowledgement: I warmly thank Eleanore Hickey for her
help in stylistic ameliorations of the English language.
Funding / potential competing interests: No financial support
and no other potential conflict of interest relevant to this article
were reported.
Correspondence: Dorothea Wunder, MD, Reproductive
Medicine, Department of Gynaecology and Obstetrics,
University hospital CHUV, Avenue Pierre Decker 2, CH-1011
Lausanne, Switzerland, dorothea.wunder[at]chuv.ch
References
1 Franz MB, Husslein PW. Obstetrical management of the older gravida.
Womens Health. (Lond Engl) 2010;6:463–8.
2 Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends
in hypertension prevalence, awareness, treatment, and control rates in
United States adults between 1988–1994 and 1999–2004. Hyperten-
sion. 2008;52:818–27.
3 Kort DH, Gosselin J, Choi JM, Thornton MH, Cleary-Goldman J, Sauer
MV. Pregnancy after age 50: Defining risks for mother and child. Am J
Perinatol. 2012;29:245–50.
4 Simchen MJ, Yinon Y, Moran O, Schiff E, Sivan E. Pregnancy outcome
after age 50. Obstet Gynecol. 2006;26:3054–60.
5 Glasser S, Segev-Zahav A, Fortinsky P, Gedal-Beer D, Schiff E, Lerner-
Geva L. Primiparity at very advanced maternal age (≥45 years). Fertil
Steril. 2011;95:2548–51.
6 Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Com-
stock CH, et al.; FASTER Consortium. Impact of maternal age on ob-
stetric outcome. Obstet Gynecol. 2005;105:983–90.
7 Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40:
pregnancy outcome in 24,032 cases. Obstet Gynecol. 1999;93:9–14.
8 Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap
S. Risk factors for pre-eclampsia in nulliparous and parous women: the
Jerusalem perinatal study. Paediatr Perinat Epidemiol. 2005;19:59–68.
9 Delbaere I, Verstraelen H, Goetgeluk S, Martens G, De Backer G, Tem-
merman M. Pregnancy outcome in primiparae of advanced maternal
age. Eur J Obstet Gynecol Reprod Biol. 2007;135:41–6.
10 Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse
perinatal outcome. Obstet Gynecol. 2004;104:727–33.
11 Bottino MN, Nadanovsky P, Moraes CL, Reichenheim ME, Lobato G.
Reappraising the relationship between maternal age and postpartum de-
pression according to the evolutionary theory: Empirical evidence from
a survey in primary health services. J Affect Disord. 2012 Jul 25 [Epub
ahead of print].
12 Varvarigou AA. Intrauterine growth restriction as a potential risk factor
for disease onset in adulthood. J Pediatr Endocrinol Metab.
2010;23:215–24.
13 Sutcliffe AG, Barnes J, Belsky J, Gardiner J, Melhuish E. The health
and development of children born to older mothers in the United King-
dom: observational study using longitudinal cohort data. BMJ.
2012;345:e5116. doi: 10.1136/bmj.e5116.
14 Pennings G. Age and assisted reproduction. Int J Med Law.
2005;3:531–41.
15 Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low
and very low birth weight in infants conceived with use of assisted re-
productive technology. N Engl J Med. 2002;346:731–7.
16 Allen C, Bowdin S, Harrison RF, Sutcliffe AG, Brueton L, Kirby G,
et al. Pregnancy and perinatal outcomes after assisted reproduction: a
comparative study. Ir J Med Sci. 2008;177:233–41.
17 Koivurova S, Hartikainen AL, Gissler M, Hemminki E, Sovio U,
Järvelin MR. Neonatal outcome and congenital malformations in chil-
dren born after in-vitro fertilization. Hum Reprod. 2002;17:1391–8.
18 Wisborg K, Ingerslev HJ, Henriksen TB. In vitro fertilization and pre-
term delivery, low birth weight, and admission to the neonatal intensive
care unit: a prospective follow-up study. Fertil Steril. 2010;94:2102–6.
19 Wisborg K, Ingerslev HJ, Henriksen TB. IVF and stillbirth: a prospect-
ive follow-up study. Hum Reprod. 2010;25:1312–13166.
20 Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes
in singletons following in vitro fertilization: a meta-analysis. Obstet
Gynecol. 2004;103:551–63.
21 Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome
of singletons and twins after assisted conception: a systematic review
of controlled studies. BMJ. 2004;328:261.
22 McGovern PG, Llorens AJ, Skurnick JH, Weiss G, Goldsmith LT. In-
creased risk of preterm birth in singleton pregnancies resulting from in
vitro fertilization-embryo transfer or gamete intrafallopian transfer: a
meta-analysis. Fertil Steril. 2004;82:1514–20.
23 Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted repro-
ductive technology, and adverse pregnancy outcomes: executive sum-
mary of a National Institute of Child Health and Human Development
workshop. Obstet Gynecol. 2007;109:967–77.
24 Grady R, Alavi N, Vale R, Khandwala M, McDonald SD. Elective
single embryo transfer and perinatal outcomes: a systematic review and
meta-analysis. Fertil Steril. 2012;97:324–31.
25 Nikolettos N, Asimakopoulos B, Papastefanou IS. Intracytoplasmic
sperm injection – an assisted reproduction technique that should make
us cautious about imprinting deregulation. J Soc Gynecol Investig.
2006;13:317–28.
26 Anthony S, Buitendijk SE, Dorrepaal CA, Lindner K, Braat DD, den
Ouden AL. Congenital malformations in 4224 children conceived after
IVF. Hum Reprod. 2002;17:2089–95.
27 Bonduelle M, Legein J, Buysse A, Van Assche E, Wisanto A, Devroey
P, et al. Prospective follow-up study of 423 children born after in-
tracytoplasmic sperm injection. Hum Reprod. 1996;11:1558–64.
Review article Swiss Med Wkly. 2013;143:w13746
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 5 of 6
28 Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H,
et al. Reproductive technologies and the risk of birth defects. N Engl J
Med. 2012;366:1803–13.
29 Ericson A, Källén B. Congenital malformations in infants born after
IVF: a population-based study. Hum Reprod. 2001;16:504–9.
30 Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth de-
fects after intracytoplasmic sperm injection and in vitro fertilization. N
Engl J Med. 2002;346:725–30.
31 Ludwig M, Katalinic A. Malformation rate in fetuses and children con-
ceived after ICSI: results of a prospective cohort study. Reprod Biomed
Online. 2002;5:171–8.
32 Noyes N, Reh A, McCaffrey C, Tan O, Krey L. Over 900 oocyte cryp-
reservation babies born with no apparent increase in congenital anom-
alies. Reprod Biomed Online. 2009;18:323–33.
33 Chian R, Huang J, Tan S, et al. Obstetric and perinatal outcome in
200 infants conceived from vitrified oocytes. Reprod Biomed Online.
2008;16:608–10.
34 Scherrer U, Rimoldi SF, Rexhaj E, Stuber T, Duplain H, Garcin S, et al.
Systemic and pulmonary vascular dysfunction in children conceived by
assisted reproductive technologies. Circulation. 2012;125:1890–6.
35 Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE,
Delemarre-van de Waal HA. Cardiometabolic differences in children
born after in vitro fertilization: follow-up study. J Clin Endocrinol
Metab. 2008;93:1682–8.
36 Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papas-
tamataki M, Papassotiriou I, Chrousos GP. Absence of insulin resist-
ance and low-grade inflammation despite early metabolic syndrome
manifestations in children born after in vitro fertilization. Fertil Steril.
2010;94:1693–9.
37 http://www.sgrm.org/wb/pages/de/fivnat-kommission/
38 Cobo A, Diaz C. Clinical application of oocyte vitrification: a systemat-
ic review and meta-analysis of randomized controlled trials. Fertil Ster-
il. 2011;96:277–85.
39 Broomfield DP, Vishwakarma E, Green L, Patrizio P. Slow freezing vs.
vitrification of oocytes: a comprehensive meta-analysis. Fertil Steril.
2011;96(suppl):S24.
40 Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E,
et al. Embryo development of fresh versus vitrified metaphase II oo-
cytes after ICSI: a prospective randomized sibling-oocyte study. Hum
Reprod. 2010;25:66–73.
41 Bianchi V. Oocyte slow freezing using a 0.2–0.3 M sucrose concentra-
tion protocol: is it really the time to trash the cryopreservation machine?
Fertil Steril. 2012;97:1101–7.
42 http://www.admin.ch/ch/d/sr/810_11/index.html
43 Hirshfeld-Cytron J, Grobman WA, Milad MP. Fertility preservation
for social indications: a cost-based decision analysis. Fertil Steril.
2012;97:665–70.
44 Shkedi-Rafid S, Hashiloni-Dolev A. Egg freezing for age-related fer-
tility decline: preventive medicine or a further medicalization of repro-
duction? Analyzing the new Israeli policy. Fertil Steril. 2011;96:291–4.
45 Lampic C, Svanberg AS, Karlström P, Tydén T. Fertility awareness,
intentions concerning childbearing, and attitudes towards parenthood
among female and male academics. Hum Reprod. 2006;21:558–64.
46 Bretherick KL, Fairbrother N, Avila L, Harbord SH, Robinson WP.
Fertility and aging: do reproductive-aged Canadian women know what
they need to know? Fertil Steril. 2010;93:2162–8.
Review article Swiss Med Wkly. 2013;143:w13746
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 6 of 6
